1. Home
  2. RDY vs BSAC Comparison

RDY vs BSAC Comparison

Compare RDY & BSAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDY
  • BSAC
  • Stock Information
  • Founded
  • RDY 1984
  • BSAC 1977
  • Country
  • RDY India
  • BSAC Chile
  • Employees
  • RDY N/A
  • BSAC N/A
  • Industry
  • RDY Biotechnology: Pharmaceutical Preparations
  • BSAC Commercial Banks
  • Sector
  • RDY Health Care
  • BSAC Finance
  • Exchange
  • RDY Nasdaq
  • BSAC Nasdaq
  • Market Cap
  • RDY 11.8B
  • BSAC 11.5B
  • IPO Year
  • RDY N/A
  • BSAC 1994
  • Fundamental
  • Price
  • RDY $14.22
  • BSAC $24.01
  • Analyst Decision
  • RDY Strong Buy
  • BSAC Hold
  • Analyst Count
  • RDY 2
  • BSAC 2
  • Target Price
  • RDY $16.95
  • BSAC $22.50
  • AVG Volume (30 Days)
  • RDY 1.0M
  • BSAC 269.2K
  • Earning Date
  • RDY 07-23-2025
  • BSAC 10-29-2025
  • Dividend Yield
  • RDY 0.50%
  • BSAC 4.13%
  • EPS Growth
  • RDY 2.20
  • BSAC 88.01
  • EPS
  • RDY 0.79
  • BSAC 0.01
  • Revenue
  • RDY $3,897,394,052.00
  • BSAC $2,504,429,686.00
  • Revenue This Year
  • RDY $7.33
  • BSAC $41.14
  • Revenue Next Year
  • RDY $1.96
  • BSAC $5.30
  • P/E Ratio
  • RDY $18.01
  • BSAC $9.89
  • Revenue Growth
  • RDY 15.86
  • BSAC 38.82
  • 52 Week Low
  • RDY $12.26
  • BSAC $18.19
  • 52 Week High
  • RDY $16.71
  • BSAC $25.53
  • Technical
  • Relative Strength Index (RSI)
  • RDY 46.98
  • BSAC 52.30
  • Support Level
  • RDY $14.08
  • BSAC $23.31
  • Resistance Level
  • RDY $14.59
  • BSAC $24.07
  • Average True Range (ATR)
  • RDY 0.17
  • BSAC 0.41
  • MACD
  • RDY 0.04
  • BSAC 0.02
  • Stochastic Oscillator
  • RDY 44.87
  • BSAC 50.36

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

About BSAC Banco Santander - Chile ADS

Founded in 1978, Banco Santander Chile is part of Santander Group and majority-controlled by Santander Spain. It is the largest bank in Chile by loans and the second largest by deposits. The bank generates most of its net interest income (roughly 65% of total revenue) from its mortgages, unsecured consumer credit lines, and commercial loans. Banco Santander's commercial loan business is more focused on small- to medium-size companies, with firms generating more than CLP 10,000 million in revenue only making up around 5% of outstanding loans. Outside of lending, Banco Santander is the largest card issuer in the country with around 25% of the market and benefits from a long-term strategic partnership with the largest airline in the country, LATAM.

Share on Social Networks: